{"nct_id":"NCT02757105","title":"Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2016-05-19","start_date_type":"ACTUAL","primary_completion_date":"2017-06-16","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["RDHL"]}